Attention! Cardiovascular Disease is Not Your Enemy (Anymore)
Enhanced External Counterpulsation (EECP) is a non-invasive therapy approved by FDA for patients with refractory angina pectoris who are not fit for either coronary artery bypass graft surgery (CABG) or revascularization because of their unsuitable health condition. 2.4 million people in the US estimated with Cardiovascular Disease (CAD) are not suitable candidates for bypass or…
Read more